Primary delusions are unique in that they cannot be attributed to any previous psychopathological state, such as a mood disorder. Delusions are characterized by an unshakeable, false belief that is not accepted by others in the patient’s culture. The patient perceives no difference between a delusional belief and a true belief.

The correct answer is Schizophrenia, as primary delusions are often observed in this disorder and other psychotic disorders. In contrast, mania and severe depression are more likely to cause secondary delusions that are related to the patient’s underlying mood.

Anorexia nervosa typically does not involve true delusions, but it may involve over-valued ideas that the person becomes preoccupied with.

Understanding Psychosis: Symptoms and Associated Features

Psychosis is a term used to describe a person’s experience of perceiving things differently from those around them. This can manifest in a variety of ways, including hallucinations, delusions, thought disorganization, alogia, tangentiality, clanging, and word salad. These symptoms can be associated with agitation, aggression, neurocognitive impairment, depression, and thoughts of self-harm.

Psychotic symptoms can occur in a number of conditions, including schizophrenia, depression, bipolar disorder, puerperal psychosis, brief psychotic disorder, neurological conditions like Parkinson’s disease and Huntington’s disease, and as a result of prescribed drugs or certain illicit drugs like cannabis and phencyclidine.

The peak age of first-episode psychosis is around 15-30 years. It is important to understand the symptoms and associated features of psychosis in order to recognize and seek appropriate treatment for those experiencing these symptoms.

Psychomotor Retardation in Severe Depression

Psychomotor retardation is a cognitive symptom commonly observed in individuals with severe depression. It is characterized by a significant slowing down of both thinking and behavior. This symptom can manifest in various ways, such as slowed speech, reduced movement, and delayed responses.

In contrast, other disorders such as mania and schizophrenia are associated with different forms of thought disorders. Mania is characterized by racing thoughts and impulsivity, while schizophrenia is associated with disorganized thinking and delusions.

It is important to recognize the presence of psychomotor retardation in individuals with severe depression as it can significantly impact their daily functioning and quality of life. Treatment options for this symptom may include medication, psychotherapy, and lifestyle changes. By addressing this symptom, individuals with severe depression can improve their overall well-being and ability to function in their daily lives.

Personality Disorders: General Criteria and Specific Types

Personality disorders are a group of mental health conditions that are characterised by deviations from the cultural norm in cognition, affect, impulse control, or relating to others. According to ICD-10, individuals diagnosed with a personality disorder must meet certain general criteria, including long-term evidence of the deviation since childhood or adolescence, distress to the individual or negative impact on their social environment, and the absence of an alternative mental disorder or organic brain injury.

There are several specific types of personality disorders, each with their own unique characteristics. Histrionic personality disorder is characterised by self-dramatisation, suggestibility, shallow affectivity, and a continual seeking for excitement and attention. Borderline personality disorder is associated with disturbances in self-image, intense relationships, emotional crises, and deliberate self-harm. Anankastic personality disorder is similar to obsessive-compulsive personality disorder, with individuals becoming preoccupied with detail, rules, and schedules to the point of hindering completion of tasks and relationships. Schizoid personality disorder is characterised by emotional detachment and solitary activities, while paranoid personality disorder involves high levels of suspicion and distrust towards others.

Patients with moderate depression exhibit elevated cortisol levels. The neurotrophic hypothesis suggests that depression-induced glutamate increase leads to cellular atrophy and reduced BDNF, which typically safeguards neurons. The immunological hypothesis proposes that depression can imitate the sick role by raising inflammatory cytokines and interleukins, such as interferon-alpha and tumor necrosis factor. The psychological hypothesis posits that mood changes stem from dysfunctional core beliefs, which cause cognitive distortions about oneself, others, and the world, forming the foundation of CBT. The monoamine hypothesis suggests that depressed patients have insufficient monoamine levels, which regulate mood. In depression, there is an increased density of MAO-A (metabolizer). Citalopram functions by restricting monoamine reuptake into the presynaptic cell, thereby increasing the monoamine levels available to the postsynaptic receptor, indicating that it operates based on the monoamine hypothesis.

Screening and Assessment of Depression

Depression is a common mental health condition that affects many people worldwide. Screening and assessment are important steps in identifying and managing depression. The screening process involves asking two simple questions to determine if a person is experiencing symptoms of depression. If the answer is yes to either question, a more in-depth assessment is necessary.

Assessment tools such as the Hospital Anxiety and Depression (HAD) scale and the Patient Health Questionnaire (PHQ-9) are commonly used to assess the severity of depression. The HAD scale consists of 14 questions, seven for anxiety and seven for depression. Each item is scored from 0-3, producing a score out of 21 for both anxiety and depression. The PHQ-9 asks patients about nine different problems they may have experienced in the last two weeks, which can then be scored from 0-3. This tool also includes questions about thoughts of self-harm.

The DSM-IV criteria are used by NICE to grade depression. This criteria includes nine different symptoms, such as depressed mood, diminished interest or pleasure in activities, and feelings of worthlessness or guilt. The severity of depression can range from subthreshold depressive symptoms to severe depression with or without psychotic symptoms.

In conclusion, screening and assessment are crucial steps in identifying and managing depression. By using tools such as the HAD scale and PHQ-9, healthcare professionals can accurately assess the severity of depression and provide appropriate treatment.

Overvalued Ideas

An overvalued idea is a comprehensible and acceptable belief that dominates a person’s life and preoccupies their mind. It is not a delusion, and the person acknowledges the possibility that their belief may or may not be true. However, they pursue their aim with an overwhelming desire. Despite the intensity of their belief, the person remains functioning, and there is no evidence of psychotic symptoms.

According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), an overvalued idea is an unreasonable and sustained belief that is maintained with less than delusional intensity. This means that the person is aware that their belief may not be accepted by others in their culture or subculture.

In summary, an overvalued idea is a strong belief that is not firmly fixed as true, but still dominates a person’s life. It is not a delusion, and the person remains functioning. overvalued ideas is important in distinguishing them from delusions and other mental health conditions.

Psychomotor Retardation in Depression

Psychomotor retardation is a common manifestation of depression, characterized by slow movement, speech, and rigidity in limbs. Patients may also exhibit a bent body posture and feelings of emptiness and hopelessness. It is crucial to rule out other potential causes, such as medication side effects or neurological disorders like Parkinson’s disease.

In severe cases, psychomotor retardation can progress to catatonia, where the patient is unresponsive to external stimuli despite being awake. It is essential to recognize and address these symptoms promptly to ensure proper diagnosis and treatment. By the signs and symptoms of psychomotor retardation, healthcare professionals can provide appropriate care and support to individuals experiencing depression.

Citalopram works by selectively inhibiting the reuptake of serotonin, while atomoxetine inhibits the reuptake of norepinephrine. Modafinil acts as a dopamine reuptake inhibitor, and methylphenidate inhibits the reuptake of both norepinephrine and dopamine. Haloperidol is an example of an antipsychotic medication.

In March 2018, NICE released new guidelines for the recognition and management of Attention Deficit Hyperactivity Disorder (ADHD). This condition can have a significant impact on a child’s life and can continue into adulthood, making accurate diagnosis and treatment crucial. ADHD is defined by DSM-V as a persistent condition that includes features of inattention and/or hyperactivity/impulsivity, with an element of developmental delay. The threshold for diagnosis is six features for children up to 16 years old and five features for those aged 17 or over. ADHD has a prevalence of 2.4% in the UK, with a possible genetic component and a higher incidence in boys than girls.

NICE recommends a holistic approach to treating ADHD that is not solely reliant on medication. After presentation, a ten-week observation period should follow to determine if symptoms change or resolve. If symptoms persist, referral to secondary care is necessary, usually to a paediatrician with a special interest in behavioural disorders or to the local Child and Adolescent Mental Health Service (CAMHS). A tailored plan of action should be developed, taking into account the patient’s needs and wants and how their condition affects their lives.

Drug therapy should be considered a last resort and is only available to those aged 5 years or older. For patients with mild/moderate symptoms, parents attending education and training programmes can be beneficial. For those who fail to respond or have severe symptoms, pharmacotherapy can be considered. Methylphenidate is the first-line treatment for children and should be given on a six-week trial basis. Lisdexamfetamine can be used if there is an inadequate response, and dexamfetamine can be started in those who have benefited from lisdexamfetamine but cannot tolerate its side effects. In adults, methylphenidate or lisdexamfetamine are first-line options, with switching between drugs if no benefit is seen after a trial of the other.

All of these drugs have the potential to be cardiotoxic, so a baseline ECG should be performed before starting treatment. Referral to a cardiologist is necessary if there is any significant past medical history or family history, or any doubt or ambiguity. A thorough history and clinical examination are essential for accurate diagnosis, given the overlap of ADHD with many other psychiatric and physical conditions.

The two types of GABA receptor are GABA-A and GABA-B. GABA-A receptors are ionotropic receptors that function as ligand-gated ion channels. When GABA binds to these receptors, the channel opens and allows ions to pass through. This results in an influx of chloride ions, which reduces the membrane potential and produces sedative effects.

Benzodiazepines are drugs that enhance the effect of the neurotransmitter GABA, which has an inhibitory effect on the brain. This makes them useful for a variety of purposes, including sedation, anxiety relief, muscle relaxation, and as anticonvulsants. However, patients can develop a tolerance and dependence on these drugs, so they should only be prescribed for short periods of time. When withdrawing from benzodiazepines, it is important to do so gradually, reducing the dose every few weeks. If patients withdraw too quickly, they may experience benzodiazepine withdrawal syndrome, which can cause a range of symptoms including insomnia, anxiety, and seizures. Other drugs, such as barbiturates, work in a similar way but have different effects on the duration or frequency of chloride channel opening.

Tardive dyskinesia is a condition that can occur as a result of long-term use of antipsychotic drugs, which is likely in this patient due to his history of mental illness. It is believed that blocking the dopamine receptor can cause hypersensitivity of the D2 receptor in the nigrostriatal pathway, leading to excessive movements.

It should be noted that antiemetic medications that use dopamine antagonism in the chemoreceptor trigger zone are more likely to cause acute dystonias rather than tardive dyskinesia. Additionally, degeneration of dopaminergic neurons in the substantia nigra is associated with Parkinson’s disease and would not produce these symptoms. Abrupt withdrawal of dopaminergic agents is also not expected to result in tardive dyskinesia. Finally, carbidopa inhibits the conversion of L-DOPA into dopamine and does not cause tardive dyskinesia.

Antipsychotics are a type of medication used to treat schizophrenia, psychosis, mania, and agitation. They are divided into two categories: typical and atypical antipsychotics. The latter were developed to address the extrapyramidal side-effects associated with the first generation of typical antipsychotics. Typical antipsychotics work by blocking dopaminergic transmission in the mesolimbic pathways through dopamine D2 receptor antagonism. However, they are known to cause extrapyramidal side-effects such as Parkinsonism, acute dystonia, akathisia, and tardive dyskinesia. These side-effects can be managed with procyclidine. Other side-effects of typical antipsychotics include antimuscarinic effects, sedation, weight gain, raised prolactin, impaired glucose tolerance, neuroleptic malignant syndrome, reduced seizure threshold, and prolonged QT interval. The Medicines and Healthcare products Regulatory Agency has issued specific warnings when antipsychotics are used in elderly patients due to an increased risk of stroke and venous thromboembolism.

Weight gain is a prevalent side effect of antipsychotics.

While antipsychotics are successful in treating schizophrenia, they often lead to weight gain and an increased likelihood of developing type 2 diabetes. The most rapid weight gain typically occurs within the first six months of starting antipsychotic treatment.

In particular, Olanzapine and Clozapine are associated with a high risk of weight gain. They stimulate appetite and result in overeating, as well as disrupt glucose regulation.

Schizophrenia management guidelines were published by NICE in 2009. The guidelines recommend that first-line treatment for schizophrenia should involve oral atypical antipsychotics. Additionally, cognitive behavioural therapy should be offered to all patients. It is important to pay close attention to cardiovascular risk-factor modification due to the high rates of cardiovascular disease in schizophrenic patients, which is linked to antipsychotic medication and high smoking rates. Therefore, healthcare professionals should take necessary measures to reduce the risk of cardiovascular disease in these patients.